Medical Nonwoven Global Market Report 2026

Medical nonwovens are engineered fabrics manufactured by bonding synthetic or natural fibers without weaving or knitting, specifically designed for healthcare applications. They are lightweight, breathable, and typically single-use, offering effective hygiene and barrier protection. Medical nonwovens help reduce infection transmission and improve safety for both patients and healthcare professionals, while also supporting cost-efficient and streamlined clinical operations due to their disposable nature and ease of production.

The primary types of medical nonwoven comprise spunbond, spun-melt-spun (SMS), drylaid, wetlaid, meltblown, and other types. Spunbond refers to nonwoven fabric produced by extruding thermoplastic polymers into continuous filaments that are laid and bonded to form strong, lightweight, and breathable medical-grade materials. The material framework comprises polypropylene, polyethylene, polyester, rayon, and other material types and they are distributed through direct sales, online retail, medical supply distributors, pharmacies, and wholesale suppliers. The key applications of direct sales, distributors, and online sales channels, while the end-use includes hospital, clinics, home healthcare, laboratory, ambulatory surgical centres, and other end-users.

Tariffs are influencing the medical nonwovens market by increasing the cost of imported raw materials such as polypropylene, polyester, and specialty polymers used in disposable medical textiles and infection-control products. This is affecting production economics for high-volume segments including spunbond, SMS, and meltblown nonwovens, while slowing procurement cycles across hospitals, clinics, and surgical centers. Regions heavily reliant on imports, such as Asia-Pacific and Europe, are experiencing the greatest impact due to supply chain disruptions and elevated landed costs. However, tariffs are also encouraging manufacturing localization, regional supplier diversification, and increased investments in domestic nonwoven production ecosystems, thereby strengthening long-term supply resilience and innovation within the healthcare textile industry.

The medical nonwoven market research report is one of a series of new reports from The Business Research Company that provides medical nonwoven market statistics, including medical nonwoven industry global market size, regional shares, competitors with a medical nonwoven market share, detailed medical nonwoven market segments, market trends and opportunities, and any further data you may need to thrive in the medical nonwoven industry. This medical nonwoven market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The medical nonwoven market size has grown strongly in recent years. It will grow from $11.49 billion in 2025 to $12.31 billion in 2026 at a compound annual growth rate (CAGR) of 7.1%. The growth in the historic period can be attributed to rise in hospital-acquired infections awareness, growth of disposable healthcare products, expansion of global healthcare infrastructure, increasing surgical procedures worldwide, demand for cost-effective hygiene solutions.

The medical nonwoven market size is expected to see strong growth in the next few years. It will grow to $16.32 billion by 2030 at a compound annual growth rate (CAGR) of 7.3%. The growth in the forecast period can be attributed to aging global population, rising chronic disease prevalence, advancement in biodegradable nonwoven materials, expansion of home healthcare services, stricter infection control regulations. Major trends in the forecast period include rising demand for disposable infection-control medical textiles, expansion of surgical-grade barrier protection materials in hospitals, growth of cost-effective single-use hygiene products in healthcare, increasing adoption of high-filtration nonwoven materials in wound care, surge in demand for lightweight breathable medical fabrics in home healthcare.

The increasing number of surgical procedures is expected to propel the growth of the medical nonwoven market going forward. Surgical procedures refer to medical interventions performed in operating rooms that involve incisions, tissue manipulation, or suturing, typically conducted under anesthesia. The rising volume of surgical procedures is contributing to this growth due to the increasing prevalence of chronic diseases such as cardiovascular disorders, cancer, and diabetes, as these conditions often necessitate operative interventions for effective management. The higher frequency of surgeries is further supporting increased consumption of medical nonwovens, as these materials are essential components of sterile drapes, surgical gowns, face masks, and wound care products used throughout every operative procedure. For instance, in June 2024, according to the American Society of Plastic Surgeons, a US-based professional medical organization, in 2023, liposuction continued to be the most sought-after plastic surgery procedure, with nearly 350,000 procedures performed, marking a 7% increase compared to 2022. Therefore, the increasing number of surgical procedures is propelling the growth of the medical nonwoven market.

The growing prevalence of chronic diseases is expected to propel the growth of the medical nonwoven market going forward. Chronic diseases are long-term health conditions such as diabetes, heart disease, and cancer that require continuous medical management and care. The rising prevalence of chronic diseases is largely contributing to market expansion, driven by aging populations, as older individuals are significantly more susceptible to developing multiple chronic conditions simultaneously, thereby placing sustained and increasing pressure on healthcare systems. The growing burden of chronic diseases is further supporting and amplifying the demand for sterile, single-use protective medical products used in wound care, surgical procedures, and patient management, thereby directly fueling the consumption of medical nonwoven materials. For instance, in January 2026, according to the Centers for Disease Control and Prevention (CDC), a US-based government public health agency, the estimated number of people with diagnosed or undiagnosed diabetes in the United States increased from 37.3 million in 2022 to over 40.1 million in 2023, reflecting a notable rise in chronic disease burden across the country. Therefore, the growing prevalence of chronic diseases is propelling the growth of the medical nonwoven market.

Leading companies operating in the medical nonwoven market are focusing on developing advanced solutions such as binder-free bio-based nonwovens to improve sustainability, enhance material performance, and reduce environmental impact in healthcare applications. Binder-free bio-based nonwovens refer to innovative fabric materials that eliminate the need for chemical binders, offering improved biodegradability, softness, and strength while maintaining high hygiene standards. For example, in November 2025, Freudenberg Performance Materials, a Germany-based nonwoven manufacturer, launched wetlaid nonwovens combining wood pulp and polylactic acid (PLA). This innovative material combines renewable PLA fibers with wood pulp to deliver enhanced absorbency, strength, and environmental sustainability. Designed to support applications in hygiene and potential medical use, the product aligns with growing demand for eco-friendly disposable materials in healthcare and contributes to reducing reliance on synthetic, non-biodegradable nonwoven solutions.

Major companies operating in the medical nonwoven market are Kimberly-Clark Corporation, Asahi Kasei Corporation, Toray Industries Inc., DuPont de Nemours Inc., Unicharm Corporation, Johns Manville Corporation, Ahlstrom Holding 3 Oy, Freudenberg Performance Materials GmbH & Co. KG, Sateri Jiangxi Chemical Fibre Co. Ltd., Suominen Corporation, China Lucky Film Corporation, PFNonwovens a. s., Fibertex Nonwovens A/S, Zhejiang Xinlong Nonwoven Material Co. Ltd., Redifil Nonwovens Private Limited, Monadnock Non-Woven LLC, Mogul Nonwovens Sanayi ve Ticaret A. S., Applied Nonwoven Industries Inc., SAAF Nonwoven Pty Ltd, Dalian Ruiguang Nonwoven Group Co. Ltd.

North America was the largest region in the medical nonwoven market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the medical nonwoven market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the medical nonwoven market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The medical nonwoven consists of sales of surgical masks, isolation gowns, surgical drapes, and wound dressings. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Medical Nonwoven Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses medical nonwoven market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for medical nonwoven ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The medical nonwoven market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Type: Spunbond; Spun-Melt-Spun (SMS); Drylaid; Wetlaid; Melt blown; Other Types
• 2) By Material Type: Polypropylene; Polyethylene; Polyester; Rayon; Other Material Types
• 3) By Distribution Channel: Direct Sales; Distributors; Online Sales Channels
• 4) By Application: Disposable Hygiene; Infection Control; Surgery; Wound Care; Other Applications
• 5) By End-User: Hospital; Clinics; Home Healthcare; Laboratory; Ambulatory Surgical Centers; Other End-Users
• Subsegments:
• 1) By Spunbond: Polypropylene Spunbond; Polyester Spunbond; Polyethylene Spunbond; Biodegradable Polymer Spunbond; Composite Spunbond
• 2) By Spun-Melt-Spun: Polypropylene Layered Structure; Multi Layer Barrier Fabric; High Filtration Efficiency Fabric; Soft Touch Composite Fabric; Reinforced Composite Fabric
• 3) By Drylaid: Carded Nonwoven; Airlaid Nonwoven; Needlepunched Nonwoven; Thermally Bonded Drylaid; Chemically Bonded Drylaid
• 4) By Wetlaid: Wood Pulp Based Wetlaid; Synthetic Fiber Wetlaid; Blended Fiber Wetlaid; Latex Bonded Wetlaid; High Strength Wetlaid
• 5) By Melt blown: Polypropylene Melt blown; Fine Fiber Melt blown; High Absorbency Melt blown; Electrostatic Charged Melt blown; Biodegradable Melt blown
• 6) By Other Types: Hydroentangled Nonwoven; Composite Nonwoven Materials; Laminated Nonwoven Fabrics; Coated Nonwoven Fabrics; Specialty Functional Nonwoven
• Companies Mentioned: Kimberly-Clark Corporation; Asahi Kasei Corporation; Toray Industries Inc.; DuPont de Nemours Inc.; Unicharm Corporation; Johns Manville Corporation; Ahlstrom Holding 3 Oy; Freudenberg Performance Materials GmbH & Co. KG; Sateri Jiangxi Chemical Fibre Co. Ltd.; Suominen Corporation; China Lucky Film Corporation; PFNonwovens a.s.; Fibertex Nonwovens A/S; Zhejiang Xinlong Nonwoven Material Co. Ltd.; Redifil Nonwovens Private Limited; Monadnock Non-Woven LLC; Mogul Nonwovens Sanayi ve Ticaret A.S.; Applied Nonwoven Industries Inc.; SAAF Nonwoven Pty Ltd; Dalian Ruiguang Nonwoven Group Co. Ltd.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.